Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment

Daniele Focosi, Scott McConnell, David J. Sullivan, Arturo Casadevall
doi: https://doi.org/10.1101/2023.03.02.23286677

Article Information

doi 
https://doi.org/10.1101/2023.03.02.23286677
History 
  • March 2, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Daniele Focosi1,#,
  2. Scott McConnell2,
  3. David J. Sullivan2 and
  4. Arturo Casadevall2
  1. 1North-Western Tuscany Blood Bank, Pisa University Hospital, Italy
  2. 2Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
  1. ↵#corresponding author: daniele.focosi{at}gmail.com.

  1. Author contributions: D.F. performed literature search and wrote the first draft. A.C. revised the manuscript. D.J.S. revised the manuscript and curated Table 3. S.M. designed Figure 2.

Back to top
Posted March 02, 2023.
Download PDF
Data/Code
Email
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
Daniele Focosi, Scott McConnell, David J. Sullivan, Arturo Casadevall
medRxiv 2023.03.02.23286677; doi: https://doi.org/10.1101/2023.03.02.23286677
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area